Sickle Cell Research for Treatment and Cure
Sickle Cell Research for Treatment and Cure commemorates the 30th
anniversary of the National Sickle Cell Anemia Control Act (P. L. 92-294). The
law provided for establishment of voluntary sickle cell anemia screening and
counseling programs; information and education programs for health
professionals and the public; and research and research training in the
diagnosis, treatment, and control of sickle cell anemia. Since then, the NHLBI
has committed over $923 million for research programs to improve the lives of
persons with sickle cell disease. The booklet describes a range of NHLBI
activities, including the
- Penicillin Prophylaxis in Sickle Cell Disease
Studies.
- Multicenter Study of Hydroxyurea in Sickle Cell
Anemia.
- Stroke Prevention Trials in Sickle Cell
Anemia.
It also mentions examples of how basic science
advances achieved prior to the 1970s enabled progress against sickle cell
disease and describes ongoing studies to develop a cure.
Information about Document Format
This document is available for viewing, printing, and
downloading (saving) in Adobe Acrobat's portable document format (PDF). You
need the Acrobat Reader installed on your computer and configured to work in
your browser to access the PDF version. When viewed or printed in the Acrobat
Reader, the document appears as it does in the printed copy version.
If you do not have the Acrobat Reader, you may
download a free copy from Adobe
Attention blind and
visually impaired viewers:
Access.Adobe.Com is a
tool that allows blind and visually impaired users to read any document in
Adobe PDF. The tool converts PDF documents into simple HTML or ASCII text that
can then be read by a number of common screen reading programs that synthesize
the HTML as audible speech.
[PDF document, 432 K]
|